Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Current Opinion in HIV and AIDS|September 27, 2022
HIV T-cell immunogen design and deliveryChristian Brander, Dennis Hartigan-O'ConnorHuman Gene Therapy|March 5, 2002
Efficient rescue of gutted adenovirus genomes allows rapid production of concentrated stocks without negative selectionDennis Hartigan-O'Connor, Catherine Barjot, Robert Crawford, et al.The Journal of Gene Medicine|September 11, 2002
Gutted adenoviral vector growth using E1/E2b/E3-deleted helper virusesCatherine Barjot, Dennis Hartigan-O'Connor, Giovanni Salvatori, et al.The Journal of Pediatrics|March 19, 2018
The Effect of Early Limited Formula on Breastfeeding, Readmission, and Intestinal Microbiota: A Randomized Clinical TrialValerie J Flaherman, Nicole R Narayan, Dennis Hartigan-O'Connor, et al.Proceedings of the National Academy of Sciences of the United States of America|September 25, 2002
Functional correction of adult mdx mouse muscle using gutted adenoviral vectors expressing full-length dystrophinChristiana DelloRusso, Jeannine M Scott, Dennis Hartigan-O'Connor, et al.Biorxiv : the Preprint Server for Biology|November 24, 2025
Characterization of immunosenescent alveolar macrophages in rhesus macaquesJefferson G C Nagle, Raneesh Ramarapu, Laurent Zablocki-Thomas, et al.Frontiers in Immunology|July 5, 2022
T-Follicular-Like CD8<sup>+</sup> T Cell Responses in Chronic HIV Infection Are Associated With Virus Control and Antibody Isotype Switching to IgGLuis Romero-Martín, Ferran Tarrés-Freixas, Núria Pedreño-López, et al.Science Translational Medicine|June 15, 2022
The balance between protective and pathogenic immune responses to pneumonia in the neonatal lung is enforced by gut microbiotaJoseph Stevens, Shelby Steinmeyer, Madeline Bonfield, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 12, 2020
TL1A-DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1-Specific T Cell ResponsesBruna Oriol-Tordera, Alex Olvera, Clara Duran-Castells, et al.Ebiomedicine|March 24, 2022
Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcomeBruna Oriol-Tordera, Anna Esteve-Codina, María Berdasco, et al.Pageof 2